Physician

Abhijit B Saste

According to 2025 Medicare claims, Abhijit Saste (NPI: 1639361850) practices internal medicine in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is PROMEDICA MULTI SPECIALTY PHYSICIANS (NPI: 1306105150; TIN: 34-1881137) and primary practice location at 48162-7815. Saste is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016), McAuley Health Partners ACO, LLC (ACO ID: A4588), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Saste's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 986 HCPCS/CPT codes, and received $85,197 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,771 prescription claims across 283 beneficiaries totaling $3,915,474 in drug costs, led by Erleada (Apalutamide). DME data shows 131 claims. Open Payments data shows 24 records totaling $385. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,805 to $85,197. Similarly, Part D prescription costs have risen steadily, from $107,540 to $3,915,474. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$45K$90K2016 Medicare payment: $1,805 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $14,920 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $50,902 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $56,211 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $60,111 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $60,409 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $72,210 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $90,236 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $85,197 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20161919$1,805
2017104210$14,920
2018233757$50,902
2019248769$56,211
2020306812$60,111
2021313793$60,409
2022324901$72,210
20233811,076$90,236
2024356986$85,197

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$3.9M2015 Drug cost: $107,540 (USD; Tot_Drug_Cst)2016 Drug cost: $272,625 (USD; Tot_Drug_Cst)2017 Drug cost: $514,289 (USD; Tot_Drug_Cst)2018 Drug cost: $1,423,371 (USD; Tot_Drug_Cst)2019 Drug cost: $1,991,560 (USD; Tot_Drug_Cst)2020 Drug cost: $2,522,443 (USD; Tot_Drug_Cst)2021 Drug cost: $2,815,939 (USD; Tot_Drug_Cst)2022 Drug cost: $2,531,588 (USD; Tot_Drug_Cst)2023 Drug cost: $3,559,995 (USD; Tot_Drug_Cst)2024 Drug cost: $3,915,474 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201593431$107,540
201690489$272,625
201791497$514,289
2018132848$1,423,371
20191561,308$1,991,560
20202261,727$2,522,443
20212491,838$2,815,939
20222591,612$2,531,588
20232691,771$3,559,995
20242831,771$3,915,474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$27K$53K2017 Medicare payment: $6,114 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $8,358 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,072 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,482 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $755 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,524 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $53,473 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$6,114
2018N/R58$8,358
2019N/R23$3,072
2020N/R47$2,482
2021N/RN/RN/R
2022N/R22$755
2023N/R86$8,524
2024N/R131$53,473

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more141337$115
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes5354$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more155238$78
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3749$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more88120$46

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErleadaApalutamide27810$394,604
RevlimidLenalidomide22497$324,757
ScemblixAsciminib Hydrochloride14420$291,810
LenalidomideLenalidomide24588$270,627
KisqaliRibociclib Succinate13364$178,788

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8705Topotecan, oral, 0.25 mgNN/R17$51,025
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R56$715
J8999Prescription drug, oral, chemotherapeutic, nosNN/R18$639
J8521Capecitabine, oral, 500 mgNN/R12$573
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R15$263

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$385Celgene Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abhijit B. Saste?

Tedicare shows public-source Medicare data for Abhijit B. Saste (NPI 1639361850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhijit B. Saste have ACO affiliation data?

Abhijit B. Saste is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016), McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Abhijit B. Saste?

Abhijit B. Saste is linked to PROMEDICA MULTI SPECIALTY PHYSICIANS (billing NPI 1306105150) in the available physician profile data.

Does Abhijit B. Saste have Open Payments data?

Abhijit B. Saste has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.